Rezultati - Denice Tsao‐Wei

  • Showing 1 - 16 results of 16
Refine Results
  1. 1
    Early Ductal Decompression Versus Conservative Management for Gallstone Pancreatitis With Ampullary Obstruction

    Early Ductal Decompression Versus Conservative Management for Gallstone Pancreatitis With Ampullary Obstruction od Juan M. Acosta, Namir Katkhouda, Khaldoun A. Debian, Susan Groshen, Denice Tsao‐Wei, Thomas V. Berne

    Izdano 2005
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    Susceptibility of Nonpromoter CpG Islands to De Novo Methylation in Normal and Neoplastic Cells

    Susceptibility of Nonpromoter CpG Islands to De Novo Methylation in Normal and Neoplastic Cells od Cuong Nguyen, Gangning Liang, Tuyen Thi Thanh Nguyen, Denice Tsao‐Wei, Susan Groshen, Michael Lübbert, Jiajun Zhou, William F. Benedict, Peter A. Jones

    Izdano 2001
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    Assessing the New American Society of Clinical Oncology/College of American Pathologists Guidelines for HER2 Testing by Fluorescence In Situ Hybridization: Experience of an Academic Consultation Practice

    Assessing the New American Society of Clinical Oncology/College of American Pathologists Guidelines for HER2 Testing by Fluorescence In Situ Hybridization: Experience of an Academi... od Michael F. Press, Ivonne Villalobos, Angela Santiago, Roberta Guzman, Monica Cervantes, Armen Yuri Gasparyan, Anaamika Campeau, Yanling Ma, Denice Tsao‐Wei, Susan Groshen

    Izdano 2016
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    <i>RUNX3</i> Methylation Reveals that Bladder Tumors Are Older in Patients with a History of Smoking

    <i>RUNX3</i> Methylation Reveals that Bladder Tumors Are Older in Patients with a History of Smoking od Erika M. Wolff, Gangning Liang, Connie C. Cortez, Yvonne Tsai, Jose E. Castelao, Victoria K. Cortessis, Denice Tsao‐Wei, Susan Groshen, Peter A. Jones

    Izdano 2008
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  5. 5
    Safety and feasibility of fasting in combination with platinum-based chemotherapy

    Safety and feasibility of fasting in combination with platinum-based chemotherapy od Tanya B. Dorff, Susan Groshen, Agustin A. García, Manali Shah, Denice Tsao‐Wei, Huyen Q. Pham, Chia‐Wei Cheng, Sebastian Brandhorst, Pinchas Cohen, Min Wei, Valter D. Longo, David I. Quinn

    Izdano 2016
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  6. 6
    A Phase I Study of the Combination of Rituximab and Ipilimumab in Patients with Relapsed/Refractory B-Cell Lymphoma

    A Phase I Study of the Combination of Rituximab and Ipilimumab in Patients with Relapsed/Refractory B-Cell Lymphoma od Joseph M. Tuscano, Emanual Maverakis, Susan Groshen, Denice Tsao‐Wei, Guillaume Luxardi, Alexander A. Merleev, Anne Beaven, John F. DiPersio, Leslie Popplewell, Robert Chen, Mark Kirschbaum, Mark A. Schroeder, Edward M. Newman

    Izdano 2019
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  7. 7
    Phase I Study of Vincristine, Irinotecan, and 131I-Metaiodobenzylguanidine for Patients with Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial

    Phase I Study of Vincristine, Irinotecan, and 131I-Metaiodobenzylguanidine for Patients with Relapsed or Refractory Neuroblastoma: A New Approaches to Neuroblastoma Therapy Trial od Steven G. DuBois, Louis Chesler, Susan Groshen, Randall A. Hawkins, Fariba Goodarzian, Hiroyuki Shimada, Greg Yanik, Michael Tagen, Clinton Stewart, Yaël P. Mossé, John M. Maris, Denice Tsao‐Wei, Araz Marachelian, Judith G. Villablanca, Katherine K. Matthay

    Izdano 2012
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  8. 8
    A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma

    A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma od Judith G. Villablanca, Samuel L. Volchenboum, Hwangeui Cho, Min H. Kang, Susan L. Cohn, Clarke P. Anderson, Araz Marachelian, Susan Groshen, Denice Tsao‐Wei, Katherine K. Matthay, John M. Maris, Charlotte E. Hasenauer, Scarlett Czarnecki, Hollie Lai, Fariba Goodarzian, Hiro Shimada, C. Patrick Reynolds

    Izdano 2016
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  9. 9
    Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial

    Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial od Michael D. Hogarty, David S. Ziegler, Andrea Franson, Yueh‐Yun Chi, Denice Tsao‐Wei, Kangning Liu, Rohan Vemu, Eugene W. Gerner, Elizabeth Bruckheimer, Anasheh Shamirian, Beth Hasenauer, Frank M. Balis, Susan Groshen, Murray D. Norris, Michelle Haber, Julie R. Park, Katherine K. Matthay, Araz Marachelian

    Izdano 2024
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  10. 10
    <i>HER2</i> Gene Amplification Testing by Fluorescent In Situ Hybridization (FISH): Comparison of the ASCO-College of American Pathologists Guidelines With FISH Scores Used for Enrollment in Breast Cancer International Research Group Clinical Trials

    <i>HER2</i> Gene Amplification Testing by Fluorescent In Situ Hybridization (FISH): Comparison of the ASCO-College of American Pathologists Guidelines With FISH Scores Used for Enr... od Michael F. Press, Guido Sauter, Marc Buyse, Hélène Fourmanoir, Emmanuel Quinaux, Denice Tsao‐Wei, W. Eiermann, Nicholas J. Robert, Tadeusz Pieńkowski, John Crown, Miguel Martín, Vicente Valero, John R. Mackey, Valerie Bée, Yanling Ma, Ivonne Villalobos, Anaamika Campeau, Martina Mirlacher, Mary-Ann Lindsay, Dennis J. Slamon

    Izdano 2016
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  11. 11
    Phase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma: A NANT (New Approaches to Neuroblastoma Therapy) Trial

    Phase I Study of the Aurora A Kinase Inhibitor Alisertib in Combination With Irinotecan and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma: A NANT (New Approac... od Steven G. DuBois, Araz Marachelian, Elizabeth Fox, Rachel A. Kudgus, Joel M. Reid, Susan Groshen, Jemily Malvar, Rochelle Bagatell, Lars M. Wagner, John M. Maris, Randall A. Hawkins, Jesse Courtier, Hollie Lai, Fariba Goodarzian, Hiroyuki Shimada, Scarlett Czarnecki, Denice Tsao‐Wei, Katherine K. Matthay, Yaël P. Mossé

    Izdano 2016
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  12. 12
    131I-Metaiodobenzylguanidine with Intensive Chemotherapy and Autologous Stem Cell Transplantation for High-Risk Neuroblastoma. A New Approaches to Neuroblastoma Therapy (NANT) Phase II Study

    131I-Metaiodobenzylguanidine with Intensive Chemotherapy and Autologous Stem Cell Transplantation for High-Risk Neuroblastoma. A New Approaches to Neuroblastoma Therapy (NANT) Phas... od Gregory A. Yanik, Judith G. Villablanca, John M. Maris, Brian Weiss, Susan Groshen, Araz Marachelian, Julie R. Park, Denice Tsao‐Wei, Randall A. Hawkins, Barry L. Shulkin, Hollie Jackson, Fariba Goodarzian, Hiro Shimada, Jesse Courtier, Raymond J. Hutchinson, Daphne Haas-Koga, C. Beth Hasenauer, Scarlett Czarnecki, Howard M. Katzenstein, Katherine K. Matthay

    Izdano 2015
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  13. 13
    Dose Escalation Study of No-Carrier-Added <sup>131</sup>I-Metaiodobenzylguanidine for Relapsed or Refractory Neuroblastoma: New Approaches to Neuroblastoma Therapy Consortium Trial

    Dose Escalation Study of No-Carrier-Added <sup>131</sup>I-Metaiodobenzylguanidine for Relapsed or Refractory Neuroblastoma: New Approaches to Neuroblastoma Therapy Consortium Trial od Katherine K. Matthay, Brian Weiss, Judith G. Villablanca, John M. Maris, Gregory A. Yanik, Steven G. DuBois, James B. Stubbs, Susan Groshen, Denice Tsao‐Wei, Randall A. Hawkins, Hollie Jackson, Fariba Goodarzian, Heike E. Daldrup‐Link, Ashok Panigrahy, Alexander J. Towbin, Hiroyuki Shimada, John Barrett, Norman LaFrance, John W. Babich

    Izdano 2012
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  14. 14
    Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma

    Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma od Steven G. DuBois, Susan Groshen, Julie R. Park, Daphne A. Haas‐Kogan, Xiao-Dong Yang, Ethan G. Geier, Eugene Chen, Kathy Giacomini, Brian Weiss, Susan L. Cohn, M. Meaghan Granger, Gregory A. Yanik, Randall A. Hawkins, Jesse Courtier, Hollie Jackson, Fariba Goodarzian, Hiroyuki Shimada, Scarlett Czarnecki, Denice Tsao‐Wei, Judith G. Villablanca, Araz Marachelian, Katherine K. Matthay

    Izdano 2015
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  15. 15
    Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium

    Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Con... od Steven G. DuBois, Meaghan Granger, Susan Groshen, Denice Tsao‐Wei, Lingyun Ji, Anasheh Shamirian, Scarlett Czarnecki, Fariba Goodarzian, Rachel Berkovich, Hiroyuki Shimada, Judith G. Villablanca, Kieuhoa T. Vo, Navin Pinto, Yaël P. Mossé, John M. Maris, Suzanne Shusterman, Susan L. Cohn, Kelly C. Goldsmith, Brian Weiss, Gregory A. Yanik, Clare J. Twist, Meredith S. Irwin, Daphne A. Haas‐Kogan, Julie R. Park, Araz Marachelian, Katherine K. Matthay

    Izdano 2021
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  16. 16
    Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma

    Phase II Trial of Alisertib in Combination with Irinotecan and Temozolomide for Patients with Relapsed or Refractory Neuroblastoma od Steven G. DuBois, Yaël P. Mossé, Elizabeth Fox, Rachel A. Kudgus, Joel M. Reid, Renee M. McGovern, Susan Groshen, Rochelle Bagatell, John M. Maris, Clare J. Twist, Kelly C. Goldsmith, Meaghan Granger, Brian Weiss, Julie R. Park, Margaret E. Macy, Susan L. Cohn, Greg Yanik, Lars M. Wagner, Randall A. Hawkins, Jesse Courtier, Hollie Lai, Fariba Goodarzian, Hiroyuki Shimada, Najee Boucher, Scarlett Czarnecki, Chunqiao Luo, Denice Tsao‐Wei, Katherine K. Matthay, Araz Marachelian

    Izdano 2018
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: